Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (191-200 of 481) with videos related to

Pageof 49
Sort By:
Journal of Cancer|May 5, 2012
Liver directed therapy for renal cell carcinomaRussell C Langan, R Taylor Ripley, Jeremy L Davis, et al.
Journal of Pediatric Hematology/Oncology|September 10, 2002
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levelsPatrick J Mansky, David J Liewehr, Seth M Steinberg, et al.
Surgery|June 14, 2008
Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasiaAnathea C Powell, Constantine A Stratakis, Nicholas J Patronas, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Cancer|May 7, 2008
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006Jacob A Klapper, Stephanie G Downey, Franz O Smith, et al.
Cancer|May 17, 2002
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonistJame Abraham, Susan Bakke, Ann Rutt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersWyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
Cancer Research|December 20, 2007
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2Christine E Horak, Arnulfo Mendoza, Eleazar Vega-Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomasElizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Cancer|August 12, 2003
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized TrialMatthew M Poggi, David N Danforth, Linda C Sciuto, et al.
Pageof 49

Showing results (191-200 of 481) with videos related to

Sort By:
Pageof 49
Journal of Cancer|May 5, 2012
Liver directed therapy for renal cell carcinomaRussell C Langan, R Taylor Ripley, Jeremy L Davis, et al.
Journal of Pediatric Hematology/Oncology|September 10, 2002
Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levelsPatrick J Mansky, David J Liewehr, Seth M Steinberg, et al.
Surgery|June 14, 2008
Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasiaAnathea C Powell, Constantine A Stratakis, Nicholas J Patronas, et al.
Blood|October 22, 2014
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseThomas S Uldrick, Mark N Polizzotto, Karen Aleman, et al.
Cancer|May 7, 2008
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006Jacob A Klapper, Stephanie G Downey, Franz O Smith, et al.
Cancer|May 17, 2002
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonistJame Abraham, Susan Bakke, Ann Rutt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkersWyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
Cancer Research|December 20, 2007
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2Christine E Horak, Arnulfo Mendoza, Eleazar Vega-Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomasElizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Cancer|August 12, 2003
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized TrialMatthew M Poggi, David N Danforth, Linda C Sciuto, et al.
Pageof 49